Musculoskeletal Research Unit, Bristol Medical School, University of Bristol, Level 1 Learning and Research Building, Southmead Hospital, Westbury-On-Trym, Bristol, BS10 5NB, UK.
National Institute for Health Research Bristol Biomedical Research Centre, Bristol, UK.
BMC Musculoskelet Disord. 2022 Oct 22;23(1):932. doi: 10.1186/s12891-022-05877-7.
Patellar resurfacing is optional during total knee replacement (TKR). Some surgeons always resurface the patella, some never resurface, and others selectively resurface. Which resurfacing strategy provides optimal outcomes is unclear. We assessed the effectiveness of patellar resurfacing, no resurfacing, and selective resurfacing in primary TKR.
A systematic review and meta-analysis was performed. MEDLINE, Embase, Web of Science, The Cochrane Library, and bibliographies were searched to November 2021 for randomised-control trials (RCTs) comparing outcomes for two or more resurfacing strategies (resurfacing, no resurfacing, or selective resurfacing) in primary TKR. Observational studies were included if limited or no RCTs existed for resurfacing comparisons. Outcomes assessed were patient reported outcome measures (PROMs), complications, and further surgery. Study-specific relative risks [RR] were aggregated using random-effects models. Quality of the evidence was assessed using GRADE.
We identified 33 RCTs involving 5,540 TKRs (2,727 = resurfacing, 2,772 = no resurfacing, 41 = selective resurfacing). One trial reported on selective resurfacing. Patellar resurfacing reduced anterior knee pain compared with no resurfacing (RR = 0.65 (95% CI = 0.44-0.96)); there were no significant differences in PROMs. Resurfacing reduced the risk of revision surgery (RR = 0.63, CI = 0.42-0.94) and other complications (RR = 0.54, CI = 0.39-0.74) compared with no resurfacing. Quality of evidence ranged from high to very low. Limited observational evidence (5 studies, TKRs = 215,419) suggested selective resurfacing increased the revision risk (RR = 1.14, CI = 1.05-1.22) compared with resurfacing. Compared with no resurfacing, selective resurfacing had a higher risk of pain (RR = 1.25, CI = 1.04-1.50) and lower risk of revision (RR = 0.92, CI = 0.85-0.99).
Level 1 evidence supports TKR with patellar resurfacing over no resurfacing. Resurfacing has a reduced risk of anterior knee pain, revision surgery, and complications, despite PROMs being comparable. High-quality RCTs involving selective resurfacing, the most common strategy in the UK and other countries, are needed given the limited observational data suggests selective resurfacing may not be effective over other strategies.
髌骨表面置换术在全膝关节置换术(TKR)中是可选的。一些外科医生总是对髌骨进行表面置换,一些则从不进行表面置换,而另一些则选择性地进行表面置换。哪种表面置换策略能提供最佳效果尚不清楚。我们评估了在初次 TKR 中髌骨表面置换、不表面置换和选择性表面置换的效果。
进行了系统评价和荟萃分析。检索了 MEDLINE、Embase、Web of Science、The Cochrane Library 和参考文献,以获取 2021 年 11 月之前比较两种或多种表面置换策略(表面置换、不表面置换或选择性表面置换)在初次 TKR 中结果的随机对照试验(RCT)。如果对表面置换比较的 RCT 有限或不存在,则纳入观察性研究。评估的结果包括患者报告的结果测量(PROMs)、并发症和进一步手术。使用随机效应模型汇总特定研究的相对风险 [RR]。使用 GRADE 评估证据质量。
我们确定了 33 项 RCT,涉及 5540 例 TKR(2727 例=表面置换,2772 例=不表面置换,41 例=选择性表面置换)。一项试验报告了选择性表面置换。与不表面置换相比,髌骨表面置换可减轻膝关节前痛(RR=0.65(95%CI=0.44-0.96));PROMs 无显著差异。与不表面置换相比,表面置换可降低翻修手术的风险(RR=0.63,CI=0.42-0.94)和其他并发症的风险(RR=0.54,CI=0.39-0.74)。证据质量从高到极低。有限的观察性证据(5 项研究,TKRs=215419)表明,与表面置换相比,选择性表面置换增加了翻修风险(RR=1.14,CI=1.05-1.22)。与不表面置换相比,选择性表面置换的疼痛风险更高(RR=1.25,CI=1.04-1.50),翻修风险更低(RR=0.92,CI=0.85-0.99)。
1 级证据支持 TKR 髌骨表面置换优于不表面置换。尽管 PROMs 相似,但表面置换可降低膝关节前痛、翻修手术和并发症的风险。鉴于有限的观察性数据表明选择性表面置换可能不如其他策略有效,需要进行涉及最常见策略(英国和其他国家)的选择性表面置换的高质量 RCT。